Hamilton Capital Partners (Canada)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.7M Buy
21,267
+3,094
+17% +$1.06M 0.22% 81
2026
Q1
$6.39M Sell
18,173
-930
-5% -$332K 0.21% 78
2025
Q4
$6.25M Buy
19,103
+1,818
+11% +$577K 0.23% 81
2025
Q3
$4.88M Buy
17,285
+1,697
+11% +$492K 0.2% 88
2025
Q2
$4.35M Buy
15,588
+2,881
+23% +$816K 0.22% 89
2025
Q1
$3.96M Buy
12,707
+1,012
+9% +$299K 0.25% 86
2024
Q4
$3.05M Sell
11,695
-1,364
-10% -$405K 0.23% 91
2024
Q3
$4.21M Sell
13,059
-1,470
-10% -$481K 0.36% 75
2024
Q2
$4.54M Sell
14,529
-1,784
-11% -$524K 0.49% 63
2024
Q1
$4.64M Buy
+16,313
New +$4.77M 0.56% 52

Other funds holding AMGN

Hamilton Capital Partners (Canada)'s AMGN Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $1.06M and bringing the position to 21,267 shares worth $7.7M. The position accounts for 0.22% of the portfolio, ranked #81.

Hamilton Capital Partners (Canada) first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 21,267 shares of Amgen worth $7.7M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 3,094 Amgen shares in Q2 2026, an estimated $1.06M.
  • Amgen made up 0.22% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #81 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.